Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date 연구 성과를 극대화하기 위한 종양 환자 지원 : 스폰서분들을 위한 전략 및 고려 사항 Ashley Herrick 의학박사(PhD) 전무 이사, 종양학 프로그램 전략 담당 & Nicole Carswell 전무 이사, 환자 참여 및 모집 담당 환자의 요구 사항을 이해하는 것을 포함하여 환자 모집 및 유지 노력에 집중해야 할 때 임상 시험을 계획하는 방법을 알아보십시오. 우리는 이 환자들을 어떻게 교육하고 그들의 부담을 줄이도록 지원할 것입니까? 우리는 후원자를 위한 프로토콜 개발 고려 사항에 대해 이야기하... January 27, 2022 7:00am Path to Sophisticated Data Management Sara Doolittle, Director, Functional Services, Premier Research and Rhonda Roberts, Senior Data Scientist, Remarque Systems The modern pandemic has ushered the Biotech, Pharmaceutical, and Medical Device industry into an era where clinical trials require accelerated timelin... 5 days ago | 28 mins Diversity in Clinical Trials : A more inclusive approach in patient recruitment Kate Shaw - Founder/CEO, Innovative Trials We have seen a growing focus on patient diversity in clinical trials in recent years, but the COVID-19 vaccine trials in particular have highlighted t... February 24, 2022 2:00pm Considerations to Improve Patient Outcomes in Early Drug Development Abie Ekangaki, Ph.D., VP, Premier Research; Rupa Doshi, Ph.D., VP, Premier Research; Naomi Kautz, Sr Director, RPI Every drug development program must begin with an understanding of how the relevant key stakeholders factor into the development process. It’s not jus... February 10, 2022 3:00pm Empowering Oncology Patients to Maximize Study Outcomes Ashley Herrick, Ph.D., Exec. Dir., Oncology Program Strategy & Nicole Carswell, Exec. Dir., Patient Engagement & Recruitment Patient recruitment comprises one of the most significant initial challenges in any oncology study but engaging and retaining these patients throughou... February 3, 2022 3:00pm Alternative Designs to Traditional 3+3 Design in Phase 1 Dose Escalation Studies Abie Ekangaki, Ph.D., VP, Statistical Consulting and Andreas Schreiner, M.D., VP, Medical Affairs Neuroscience & Analgesia Phase 1 clinical trials aim to determine the maximum tolerated dose (MTD) of a new molecule with the goal of identifying a recommended Phase 2 dose (R... February 17, 2022 3:00pm How to Develop a Multi-disciplinary Clinical Research Career Bonnie Ky, MD, MSCE, FACC Join this interactive webinar session with Bonnie Ky, MD, MSCE, FACC, Editor-in-Chief of JACC: CardioOncology to learn strategies on how to develop a ... 1 month ago | 61 mins Empowering Clinical Research in a Distributed World Jeff Kenkel (Dell Technologies) and Khondoker Huq (SAS) Many Contract Research Organizations (CROs) and Sponsors are applying technology to enhance clinical trials, resulting in improvements like faster and... 1 month ago | 54 mins Synthetic Control Arms – ambition to action Sanjay Jaiswal, senior executive R&D, Accenture Life Sciences; Joe Donahue, managing partner, Acorn AI With drawn-out timelines and billions in investments, traditional clinical trial methods are increasingly a barrier to cost-efficient and timely drug ... February 17, 2022 2:30pm How to Develop a Multi-disciplinary Clinical Research Career Bonnie Ky, MD, MSCE, FACC Join this interactive webinar session with Bonnie Ky, MD, MSCE, FACC, Editor-in-Chief of JACC: CardioOncology to learn strategies on how to develop a ... 1 month ago | 61 mins Australia Webinar: Empowering Oncology Patients to Maximize Study Outcomes Ashley Herrick, Ph.D., Exec. Dir., Oncology Program Strategy & Nicole Carswell, Exec. Dir., Patient Engagement & Recruitment Patient recruitment comprises one of the most significant initial challenges in any oncology study but engaging and retaining these patients throughou... February 24, 2022 3:00am 초기 종양학 연구에서 적응적 임상시험 디자인 (Adaptive Trial Design)의 역할: 유연성과 민첩성의 최적화 Abie Ekangaki, 박사(PhD) 부회장 생물통계학 컨설팅 담당 Peter J. Larson, 의사(MD) 전무이사 의료 담당 우리는 종양학 정밀 의학 연구에서 적응적 임상시험 디자인의 역할에 대한 몇 가지 높은 수준의 통찰력을 제시할 것입니다. 이러한 적응적 임상시험 디자인이 유연성과 민첩성을 최적화하는데 어떻게 도움이 되는지 알아보고자 합니다. 이것은 몇 가지 관점을 제시하고 향후 디자인 ... 6 months ago | 44 mins Virtual trials and the next generation of pharma clinical research Trishna Bharadia, Rosamund Round, PAREXEL, Martin Gibson, NorthWest EHealth, Yan Yiannakou, Consultant Gastroenterologist Previously viewed as a ‘nice to have’ for the pharma industry, virtual clinical trials were already moving from a theoretical to a practical propositi... 10 months ago | 72 mins Considerations in Conducting Pediatric Clinical Trials Jonathan Kornstein and Heather McKenney There are many challenges inherent in pediatric clinical studies, where the traditional paradigms for evaluating pharmaceutical agents in adults often... 1 year ago | 56 mins Coordinating and delivering research in the pandemic: The UK approach Phil Troke, Gilead; Kirsty Wydenbach, MHRA; Terence Stephenson, HRA; Nick Lemoine, NIHR Clinical Research Network The acute phase of the COVID-19 pandemic tested the UK’s capacity and capability to rapidly deliver crucial clinical research at a time of immense pre... 11 months ago | 74 mins Considerations in Conducting Pediatric Clinical Trials Jonathan Kornstein and Heather McKenney There are many challenges inherent in pediatric clinical studies, where the traditional paradigms for evaluating pharmaceutical agents in adults often... 2 years ago | 57 mins Initiation & Execution of Early Oncology Clinical Trials in the Time of COVID-19 Luke Gill, B.Sc. (Hon), M.Sc., MBA and Peter Larson, M.D. Initiation and Execution of Early Oncology Clinical Trials in the Time of COVID-19 Early-phase oncology, emerging from the crisis, and research and in... 1 year ago | 46 mins New Medication Risk Score for Polypharmacy-induced Drug-Drug Interactions Jeffrey DiFrancesco, Chief Life Science Officer, Tabula Rasa Healthcare The novel Medication Safety Risk Score quantifies clinically and economically meaningful polypharmacy adverse effects based on pharmacokinetics, pharm... 3 months ago | 47 mins Machine Learning: Accelerating Submission Time for Clinical Trials Anne Lifton Clinical trials are an essential process that requires considerable time and resources to safely ensure new treatments are readily available to those ... 1 year ago | 27 mins Essential Strategies in Dermatology Clinical Trials Jasmina Jankicevic, MD, Vice President, Medical Affairs & Asya Tsaneva-Maksimova, Director Study Start-up Essential Strategies in Dermatology Clinical Trials: The Convergence of Patients, Regulations, and Study Design Competition for patients among sponso... 1 year ago | 62 mins Modernizing Your RBQM Program with Automation and Integration Kristin Mauri, Remarque Systems and Ron Burns, BA Insight A well-functioning risk-based quality monitoring (RBQM) program is a must-have for today’s clinical organizations. Historically, some RBQM systems ha... 7 months ago | 30 mins Introducing the new NIHR national Patient Recruitment Centres Helen Quinn, Dinesh Saralaya, Yan Yiannakou, Melanie Davies, Gavin Galasko, Dominic Tyer, pharmaphorum The five new NIHR national Patient Recruitment Centres (PRCs) are set to shape the future of commercial clinical trials in the UK by offering new ways... 1 year ago | 78 mins Considerations for Practical Execution of a RBQM Strategy Crystal Stone, Director, Customer Engagement and Amanda Coogan, Product Specialist Today, risk-based quality management (RBQM) of your clinical trial can be simple thanks to both integrated and standalone technology solutions. Such t... 10 months ago | 44 mins From Startup to Launch in Just One Month, With Study Start-Up Meghan Donahue, Study Start-Up Product Owner, Remarque Systems & Andrea Ochoa, VP, Global Study Start-Up, Premier Research Start-up is a crucial time in any clinical study. It can also be chaotic. Developing protocols, choosing sites, onboarding patients—every step can hav... 9 months ago | 32 mins Navigating the UK regulatory pathway to increase patient engagement with trials Gareth Powell, NIHR, Sophie Evett, Pfizer, Richard Stephens and Keith Wilson, Patient Advocates, Dominic Tyer, pharmaphorum Involving patients in clinical trial design can hugely benefit pharmaceutical research's sustainability. This pharmaphorum webinar, held in associati... 1 year ago | 68 mins Load more
